SCHEMBL15096231

SCHEMBL15096231

C=C(NCC(C)C)c1ccncn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 1/20 0.44
ALDH1A1 P00352 3/20 0.39
KMT2A Q03164 4/20 0.34
MEN1 O00255 1/20 0.34
MAPT P10636 1/20 0.34
KDM6B O15054 1/20 0.34
KDM4C Q9H3R0 1/20 0.34
GRM4 Q14833 1/20 0.34
NAMPT P43490 1/20 0.34
CYP1A2 P05177 1/20 0.33
CYP2C19 P33261 1/20 0.33
HSP90AA1 P07900 1/20 0.33
HKDC1 Q2TB90 1/20 0.33
BRD4 O60885 1/20 0.33
BRPF1 P55201 1/20 0.33
FAAH O00519 1/20 0.33
CCR8 P51685 1/20 0.33
KCNH2 Q12809 1/20 0.33
CTNNB1 P35222 1/20 0.33
WNT3A P56704 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15096236 0.81 ALDH1A1 (0.53) ALDH1A1KMT2AMEN1MAPTCYP1A2
SCHEMBL13729521 0.81 P2RX7 (0.60) P2RX7ALDH1A1KMT2AGRM4NAMPT
SCHEMBL15096235 0.76 NAMPT (0.43) ALDH1A1KMT2AKDM6BKDM4CNAMPT
SCHEMBL15096229 0.76 ALDH1A1 (0.33) ALDH1A1KMT2AMEN1MAPTCYP2C19
SCHEMBL15096232 0.71 P2RX7 (0.44) P2RX7ALDH1A1KMT2AMEN1MAPT
SCHEMBL15096234 0.69 HSD17B10 (0.36) ALDH1A1KMT2AMEN1MAPTKDM6B
SCHEMBL13134207 0.69
SCHEMBL11449275 0.68 P2RX7 (0.51) P2RX7GRM4BRD4BRPF1FAAH
SCHEMBL12763800 0.67 HRH4 (0.50) ALDH1A1KDM6BKDM4CCYP1A2CYP2C19
SCHEMBL20220998 0.67 P2RX7 (0.54) P2RX7ALDH1A1KMT2AMEN1GRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8975232-B2 Macrocyclic kinase inhibitors and uses thereof PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2015-03-10 US disclosed
US-20130178429-A1 MACROCYCLIC KINASE INHIBITORS AND USES THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2013-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130178429-A1 MACROCYCLIC KINASE INHIBITORS AND USES THEREOF MAP3K20, MAP3K11, MAP3K1 P2RX7 2779/4885ALDH1A1 3932/4885KMT2A 845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.